Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post‐hoc analysis of a long‐term open‐label study

OBJECTIVES: To determine the long‐term safety of switching to brexpiprazole from aripiprazole or non‐aripiprazole dopamine antagonists. METHODS: Post‐hoc analysis of 56‐week study of Japanese outpatients with schizophrenia switched to brexpiprazole 2 mg/day over 4‐week switching period with further...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishigooka, Jun, Inada, Ken, Niidome, Kazunari, Aoki, Kazuo, Kojima, Yoshitsugu, Iwashita, Shuichi, Yamada, Sakiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365679/
https://www.ncbi.nlm.nih.gov/pubmed/33496984
http://dx.doi.org/10.1002/hup.2777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365679/
https://www.ncbi.nlm.nih.gov/pubmed/33496984
http://dx.doi.org/10.1002/hup.2777

Ejemplares similares